Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2006-11-07
2006-11-07
Shameem, Golam M. M. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S252140, C514S326000, C514S399000, C544S122000, C544S370000, C546S210000, C548S334100
Reexamination Certificate
active
07132421
ABSTRACT:
The present invention provides compounds according to formula I and pharmaceutically acceptable salts and esters thereof, having the designations provided herein and which inhibit the interaction of MDM2 protein with a p53-like peptide and have antiproliferative activity
REFERENCES:
patent: 6593353 (2003-07-01), Gudkov et al.
patent: 6734302 (2004-05-01), Kong et al.
patent: 363 061 (1990-04-01), None
patent: 433 682 (1991-06-01), None
patent: WO 00/78725 (2000-12-01), None
patent: WO 03/051359 (2003-06-01), None
patent: WO 03/051360 (2003-06-01), None
Fotouhi Nader
Liu Emily Aijun
Vu Binh Thanh
Freistein Andrew B.
Hoffmann-La Roche Inc.
Johnston George W.
Rocha-Tramaloni Patricia S.
Shameem Golam M. M.
LandOfFree
CIS-imidazoles does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with CIS-imidazoles, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and CIS-imidazoles will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3661888